BTAI

MKT CAP:$37M

BioXcel Therapeutics Inc

Market Cap

$37M

Healthcare·Drug Manufacturers - Specialty & Generic·🇺🇸 United States·NASDAQ

Healthcare·Drug·🇺🇸·NASDAQ

Stock Price

$1.10-$0.59 (-35.00%)

Jun 5, 2026

52W High $6.8052W Low $1.02

Company Details

BioXcel Therapeutics, Inc., together with its subsidiary, OnkosXcel Therapeutics LLC, operates as a biopharmaceutical company that utilizes artificial intelligence approaches to develop medicines in neuroscience and immuno-oncology in the U...

CEO

—

IPO Date

Mar 8, 2018

Website

www.bioxceltherapeutics.com

Key Metrics TTM

Revenue

$680.0K

-63.3% YoY

Net Income

-$75M

EPS (Diluted)

Free Cash Flow

-$57M

Revenue / Share

$0.06

Gross Margin

27.8%

Operating Margin

-7395.0%

Net Margin

-11078.5%

FCF Margin

-8438.4%

P/S

54.0x

P/E

Earnings Reports

Q1 2026

May 15, 2026

$206.0K+22.6%

FY 2025

Mar 27, 2026

$642.0K-71.7%

Q4 2025

Mar 27, 2026

$256.0K-30.1%

Q3 2025

Nov 12, 2025

$98.0K-54.2%

Q2 2025

Aug 12, 2025

$120.0K-89.1%

Revenue & Profitability

Valuation

Operating Cash Flow

CapEx Spend

OpEx vs Revenue Growth (YoY)

Stock-Based Compensation

OpEx Breakdown

War Chest

Shares Outstanding

Revenue Per Employee

Revenue / Employee